Who doesn't want to hear that
Long-term data from the SELECT trial published in 2023 showed reduced major adverse cardiovascular events among adults with obesity and existing cardiovascular disease, making semaglutide a medication with implications beyond weight alone
This direct delivery method allows for more predictable and stable levels of the drug in your system, which can enhance its effectiveness in managing weight
One side effect Ive observed with tirzepatide that I have not seen with semaglutide: allodynia, a heightened skin sensitivity where normal touch feels uncomfortable or painful
The shifts in eating patterns attributed to people taking GLP-1 medications is not dissimilar to previous market disruptions, Sally Lyons Wyatt, executive vice president and practice leader at Circana, said in a statement
Their efficacy, safety profile, and convenience of administration make them a valuable tool in the treatment of obesity and related comorbidities and can help individuals seek a healthier future